Core Laboratories Inc. (NYSE:CLB) Shares Acquired by Integrated Investment Consultants LLC

Integrated Investment Consultants LLC lifted its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 19.9% in the third quarter, HoldingsChannel reports. The firm owned 16,290 shares of the oil and gas company’s stock after acquiring an additional 2,709 shares during the period. Integrated Investment Consultants LLC’s holdings in Core Laboratories were worth $302,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the stock. Headlands Technologies LLC purchased a new position in Core Laboratories during the second quarter worth $36,000. nVerses Capital LLC purchased a new stake in Core Laboratories during the 3rd quarter worth about $48,000. GAMMA Investing LLC raised its stake in Core Laboratories by 23.9% in the 2nd quarter. GAMMA Investing LLC now owns 4,425 shares of the oil and gas company’s stock valued at $90,000 after purchasing an additional 855 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in Core Laboratories by 11.9% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after purchasing an additional 600 shares in the last quarter. Finally, Signaturefd LLC boosted its stake in shares of Core Laboratories by 12.8% during the 2nd quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock worth $137,000 after purchasing an additional 767 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Trading Up 0.7 %

NYSE:CLB opened at $21.27 on Friday. The stock has a market cap of $998.63 million, a price-to-earnings ratio of 32.72, a price-to-earnings-growth ratio of 1.38 and a beta of 2.35. Core Laboratories Inc. has a one year low of $13.82 and a one year high of $25.13. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48. The business’s 50-day simple moving average is $19.27 and its 200 day simple moving average is $19.42.

Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. The company had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. Core Laboratories’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.22 EPS. As a group, sell-side analysts predict that Core Laboratories Inc. will post 0.77 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 25th. Stockholders of record on Monday, November 4th will be given a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.19%. The ex-dividend date of this dividend is Monday, November 4th. Core Laboratories’s payout ratio is currently 6.15%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CLB. Stifel Nicolaus raised their target price on shares of Core Laboratories from $18.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, July 26th. Citigroup reduced their target price on Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a report on Thursday, October 31st. Finally, StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $17.00.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.